Balance Sheet (unaudited) (USD $)	Oct. 31, 2012	Jul. 31, 2012
Current assets
Cash and cash equivalents	$ 2,176	$ 20,423
Total current assets	2,176	20,423
Other assets
Patents and patent applications (net of accumulated amortizaton)	24,210	24,553
Total assets	26,386	44,976
Liabilities
Accounts payable and accrued liabilities	58,769	55,497
Accrued salaries and wages	48,800	56,300
Due to related party	136,412	136,412
Convertible notes payable, net of debt discounts	323,019	223,693
Derivative liability	298,463	191,792
Total liabilities	865,463	663,694
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 130,607,659 shares issued and outstanding at October 31, 2012 and 126,083,416 shares issued and outstanding at July 31, 2012	130,608	126,083
Additional paid-in capital	24,055,183	23,184,094
Accumulated deficit during the development stage	(25,024,868)	(23,928,895)
Total stockholders' equity (deficit)	(839,077)	(618,718)
Total liabilities and stockholders' equity(deficit)	$ 26,386	$ 44,976